Cargando…
Advances in clinical chemistry. Volume 84 /
Annotation
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cambridge, MA :
Academic Press,
2018.
|
| Colección: | Advances in Clinical Chemistry
Volume 84 |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a22000007i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_on1018457778 | ||
| 003 | OCoLC | ||
| 005 | 20231120010241.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 180111s2018 mau o 001 0 eng d | ||
| 040 | |a YDX |b eng |e pn |c YDX |d OPELS |d OCLCF |d NLE |d CNCGM |d UPM |d OCLCQ |d N$T |d INT |d OCLCQ |d UKMGB |d UX1 |d OCLCO |d OCLCQ |d GZM |d OCLCO | ||
| 015 | |a GBB803852 |2 bnb | ||
| 016 | 7 | |a 018668623 |2 Uk | |
| 020 | |a 9780128154243 |q (electronic bk.) | ||
| 020 | |a 0128154241 |q (electronic bk.) | ||
| 020 | |z 0128152060 | ||
| 020 | |z 9780128152065 | ||
| 035 | |a (OCoLC)1018457778 | ||
| 050 | 4 | |a RB40 | |
| 072 | 7 | |a HEA |x 039000 |2 bisacsh | |
| 072 | 7 | |a MED |x 014000 |2 bisacsh | |
| 072 | 7 | |a MED |x 022000 |2 bisacsh | |
| 072 | 7 | |a MED |x 112000 |2 bisacsh | |
| 072 | 7 | |a MED |x 045000 |2 bisacsh | |
| 082 | 0 | 4 | |a 616.07/56 |2 23 |
| 245 | 0 | 0 | |a Advances in clinical chemistry. |n Volume 84 / |c edited by Gregory S. Makowski. |
| 264 | 1 | |a Cambridge, MA : |b Academic Press, |c 2018. | |
| 300 | |a 1 online resource | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 0 | |a Advances in Clinical Chemistry |v Volume 84 | |
| 500 | |a Includes index. | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Advances in Clinical Chemistry; Copyright; Contents; Contributors; Preface; Chapter One: Protein Carbamylation: Chemistry, Pathophysiological Involvement, and Biomarkers; 1. Introduction; 2. The Carbamylation Reaction; 3. Impact of Carbamylation on Protein Properties; 3.1. Alteration of Structural Properties; 3.2. Loss of Function; 3.3. Impairment of Protein-Protein and Protein-Cell Interactions; 4. Protein Carbamylation in Aging and Diseases; 4.1. Aging; 4.2. Cataract; 4.3. Chronic Kidney Disease; 4.4. Atherosclerosis; 4.5. Rheumatoid Arthritis; 4.6. Neurological Disorders. | |
| 505 | 8 | |a 5. Biomarkers of Protein Carbamylation5.1. Carbamylated Hemoglobin; 5.2. Carbamylated LDLs; 5.3. Free Carbamylated Amino Acids; 5.4. Carbamylated Albumin; 5.5. Homocitrulline; 6. Analytical Methods for the Measurement of CDPs; 6.1. Colorimetric Assay; 6.2. Immunoassay; 6.3. Chromatographic Methods; 6.4. HPLC-MS/MS; 6.5. Capillary Electrophoresis; 7. Conclusion; Conflict of Interest; References; Chapter Two: Inflammatory Response During Myocardial Infarction; 1. Introduction; 2. Inflammatory Phase; 2.1. Danger-Associated Molecular Patterns; 2.1.1. High-Mobility Group Box 1 Protein. | |
| 505 | 8 | |a 2.1.2. Extracellular ATP2.1.3. Mitochondrial DNA; 2.1.4. Heat-Shock Proteins; 2.1.5. Fibronectin; 2.1.6. Calgranulins S100; 2.1.7. Extracellular RNA; 2.2. Pattern Recognition Receptors; 2.2.1. Toll-Like Receptors; 2.2.2. Receptor for Advanced Glycation End Product; 2.2.3. NOD-Like Receptors; 2.3. The Nuclear Factor Kappa B; 2.4. The Complement System; 2.5. Reactive Oxygen Species; 2.6. Cytokines; 2.6.1. TNF-�E#x91;; 2.6.2. IL-1; 2.6.3. IL-6; 2.7. Chemokines; 2.8. Cellular Effectors; 2.8.1. Neutrophils; 2.8.2. Monocytes/Macrophages; 2.8.3. Cardiac Fibroblasts; 2.8.4. DCs and Lymphocytes. | |
| 505 | 8 | |a 3. Proliferative Phase3.1. Inflammation Suppression; 3.1.1. Cellular Effectors; 3.1.2. Molecular Signaling; 3.2. Scar Formation and Fibrosis; 3.2.1. Fibroblast Spread and Transdifferentiation; 3.2.2. Extracellular Matrix Rearrangement; 4. Maturation Phase; 5. Cardiac Remodeling; 5.1. Early Cardiac Remodeling; 5.2. Late Cardiac Remodeling; 6. MI and Atherosclerosis: A Dual Path; 7. Conclusion; References; Chapter Three: Metabolomics of Major Depressive Disorder and Bipolar Disorder: Overview and Future Perspective; 1. Introduction; 2. MDD; 2.1. Blood Samples. | |
| 505 | 8 | |a 2.2. Blood Biomarkers of Ketamine's Antidepressant Actions in Patients With MDD2.3. Urine Samples; 2.4. Cerebrospinal Fluid (CSF) Samples; 3. BD; 3.1. Postmortem Brain Samples; 3.2. Blood Samples; 3.3. Blood Biomarkers for Ketamine's Antidepressant Actions in Patients With BD; 3.4. Urine Samples; 3.5. CSF Samples; 4. Conclusion and Future Direction; Acknowledgment; Conflict of Interest; References; Chapter Four: Blood Glucose Determination: Effect of Tube Additives; 1. Introduction; 2. Literature Search; 3. Search Results; 3.1. Impact of Citrate Buffer on Glucose Concentration and Stability. | |
| 520 | 8 | |a Annotation |b Advances in Clinical Chemistry, Volume 84, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the latest and most up-to-date technologies related to the field of clinical chemistry. It is the benchmark for novel analytical approaches in the clinical laboratory. | |
| 650 | 0 | |a Clinical chemistry. | |
| 650 | 2 | |a Chemistry, Clinical |0 (DNLM)D002624 | |
| 650 | 6 | |a Chimie clinique. |0 (CaQQLa)201-0016714 | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x General. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Clinical Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Diseases. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Evidence-Based Medicine. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Internal Medicine. |2 bisacsh | |
| 650 | 7 | |a Clinical chemistry |2 fast |0 (OCoLC)fst00864330 | |
| 700 | 1 | |a Makowski, Gregory S. |q (Gregory Stephen) | |
| 776 | 0 | 8 | |i Print version: |t Advances in clinical chemistry. Volume 84. |d Cambridge, MA : Academic Press, 2018 |z 0128152060 |z 9780128152065 |w (OCoLC)1005122028 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00652423/84 |z Texto completo |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/bookseries/00652423/84 |z Texto completo |